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Aims: The aim of the present study was to determine the prevalence of diabetes, and to assess its awareness and related risk 
factors among adult Guineans.
Methods: A population-based cross-sectional survey was conducted on 1 100 adults (46.6% women) aged 35–64 years from 
Lower Guinea, during September to December 2009, using the WHO STEPwise approach of surveillance of chronic disease 
risk factors. Data were collected in three steps: demographic and behavioural risk factors, blood pressure and anthropometric 
measurements, and fasting blood cholesterol and glucose testing. A multi-stage cluster sample design was applied to generate 
nationwide representative data.
Results: The mean age of all participants was 47.3  years (SD 8.8), similarly in Conakry, rural Lower Guinea and urban Lower 
Guinea. The prevalence of diabetes was 5.7% (95% CI 4.0–8.1). Among participants with diabetes, only 44.0% were aware of their 
status. In multivariable logistic regression analysis, determinants of diabetes prevalence were urban residency, male sex, age 
group 45–64 years, increased waist circumference, hypertension and hypercholesterolemia. Male sex, rural residency, age group 
45–54 years, no formal education, waist circumference, hypertension and hypercholesterolemia were independent predictors of 
screen-detected diabetes.
Conclusion: The present study found a high prevalence and low awareness of diabetes, suggesting the need for appropriate 
actions to strengthen primary healthcare approaches towards non-communicable diseases in Guinea.
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Introduction
Diabetes mellitus and other non-communicable diseases (NCDs) 
including cardiovascular diseases, cancers and chronic 
respiratory diseases are growing public health issues worldwide.1 
Countries in sub-Saharan Africa (SSA) are now confronted with a 
burden of both communicable and non-communicable 
diseases.2–4 Thus, diabetes and other NCDs are increasing causes 
of premature deaths in Africa.5,6 However, reliable population-
based data on the magnitude of these conditions are still lacking 
in significant parts of SSA.7 Furthermore, due to limited access to 
diagnosis and treatment, and lack of and misdistribution of the 
health workforce, people with prevalent NCDs such as diabetes 
in SSA are often unaware of their condition. Similarly, the few 
people under treatment are poorly managed and, as a result, 
experience poor outcomes and high complication rates.6,8,9 
Common risk factors for diabetes in SSA include increasing age, 
urbanisation, physical inactivity, hypertension and obesity.6,10,11
Most available prevalence figures for diabetes in Africa originate 
from unstandardised estimates, making comparisons between 
countries and regions very difficult. In the case of Guinea, the few 
data available to date suggest that diabetes is an important public 
health issue, with a prevalence of 6.5% among people 
aged ≥ 35 years.12 The prevalence of undiagnosed diabetes is very 
high, ranging from 56% in urban areas to 100% in rural areas in the 
Futa Jallon region of Guinea.6 The availability of the World Health 
Organization’s STEPwise approach to surveillance (STEPS) tools 
offers the opportunity of collecting standardised and comparable 
data on NCD risk factors across countries.13 Accordingly, the 
present study aimed to assess the prevalence, awareness, 
treatment and control of diabetes, as well as related risk factors in 
Guinea, using data from a representative STEPS survey.
Methods
Study design and sample size
This study was a subnational population-based cross-sectional 
household survey designed according to a WHO STEPwise 
approach for chronic disease risk factors surveillance.13 A pilot 
study was conducted in Conakry, the most densely populated 
and accessible geographical area of the study region. This pilot 
study served to confirm the feasibility of the WHO STEPS in 
Conakry and in the Lower Guinea region and to adapt the 
protocol for the main study accordingly. The WHO STEPS 
comprises three steps: a structured questionnaire to assess the 
self-reported behavioural/lifestyle risk factors (step 1); 
measurement of blood pressure and anthropometric parameters 
(step 2); and biochemical analysis of blood samples (step 3). In 
1996, Guinea had a population of just above 7 million, distributed 
across four natural regions (Lower Guinea, Upper Guinea, Middle 
Guinea or Futa Jallon, and Forest Region).14 For logistic reasons, 
the study was restricted to the Lower Guinea region, which 
includes Conakry. Conakry is the political and economic capital, 
with the largest urbanised population, accounting for 15% of the 
total population of the country.14 The Lower Guinea region is a 
coastal region with fishing and agriculture being the main 
income-generating activities. The sample size was calculated 
using the standard formula. It was assumed that the non-
response rate would be high due to selective dropout from 
blood sample collection andor low adherence to fasting 
requirements for blood glucose testing. A multistage stratified 
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Introduction
Diabetes mellitus and other non-communicable diseases (NCDs) 
including cardiovascular diseases, cancers and chronic 
respiratory diseases are growing public health issues worldwide.1 
Countries in sub-Saharan Africa (SSA) are now confronted with a 
burden of both communicable and non-communicable 
diseases.2–4 Thus, diabetes and other NCDs are increasing causes 
of premature deaths in Africa.5,6 However, reliable population-
based data on the magnitude of these conditions are still lacking 
in significant parts of SSA.7 Furthermore, due to limited access to 
diagnosis and treatment, and lack of and misdistribution of the 
health workforce, people with prevalent NCDs such as diabetes 
in SSA are often unaware of their condition. Similarly, the few 
people under treatment are poorly managed and, as a result, 
experience poor outcomes and high complication rates.6,8,9 
Common risk factors for diabetes in SSA include increasing age, 
urbanisation, physical inactivity, hypertension and obesity.6,10,11
Most available prevalence figures for diabetes in Africa originate 
from unstandardised estimates, making comparisons between 
countries and regions very difficult. In the case of Guinea, the few 
data available to date suggest that diabetes is an important public 
health issue, with a prevalence of 6.5% among people 
aged ≥ 35 years.12 The prevalence of undiagnosed diabetes is very 
high, ranging from 56% in urban areas to 100% in rural areas in the 
Futa Jallon region of Guinea.6 The availability of the World Health 
Organization’s STEPwise approach to surveillance (STEPS) tools 
offers the opportunity of collecting standardised and comparable 
data on NCD risk factors across countries.13 Accordingly, the 
present study aimed to assess the prevalence, awareness, 
treatment and control of diabetes, as well as related risk factors in 
Guinea, using data from a representative STEPS survey.
Methods
Study design and sample size
This study was a subnational population-based cross-sectional 
household survey designed according to a WHO STEPwise 
approach for chronic disease risk factors surveillance.13 A pilot 
study was conducted in Conakry, the most densely populated 
and accessible geographical area of the study region. This pilot 
study served to confirm the feasibility of the WHO STEPS in 
Conakry and in the Lower Guinea region and to adapt the 
protocol for the main study accordingly. The WHO STEPS 
comprises three steps: a structured questionnaire to assess the 
self-reported behavioural/lifestyle risk factors (step 1); 
measurement of blood pressure and anthropometric parameters 
(step 2); and biochemical analysis of blood samples (step 3). In 
1996, Guinea had a population of just above 7 million, distributed 
across four natural regions (Lower Guinea, Upper Guinea, Middle 
Guinea or Futa Jallon, and Forest Region).14 For logistic reasons, 
the study was restricted to the Lower Guinea region, which 
includes Conakry. Conakry is the political and economic capital, 
with the largest urbanised population, accounting for 15% of the 
total population of the country.14 The Lower Guinea region is a 
coastal region with fishing and agriculture being the main 
income-generating activities. The sample size was calculated 
using the standard formula. It was assumed that the non-
response rate would be high due to selective dropout from 
blood sample collection andor low adherence to fasting 
requirements for blood glucose testing. A multistage stratified 
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cluster random sampling technique was used to recruit 
participants. Based on the proposed methodology of the STEPS 
approach, a sample size of 1 200 was estimated for each of these 
two strata (Conakry and Lower Guinea). The final population 
sample selected for the present study was 2 491 individuals.
Sampling of survey sites, households and eligible 
participants
The clusters were used as survey sites. Administratively, Guinea is 
divided into eight regions, three of which form Lower Guinea. 
Each region is further sub-divided into districts and the National 
Statistic Direction clusters each district into sectors. A cluster was 
defined as a neighbourhood in an urban and a locality in a rural 
area. The number of households per cluster ranged from 145 to 
218 in rural and 218 to 327 in urban areas.
The number of clusters required from each district was randomly 
selected from the list of National Statistic Direction. We pre-
specified the number of households to be selected per cluster to 
40. Therefore, to reach the required sample size, the total number 
of clusters selected was 63 clusters (2 491/40). In each cluster, 40 
households were randomly selected using a systematic sampling 
method. At household level, only one eligible participant was 
automatically randomly selected using the Kish sampling 
method, and a built-in personal digital assistant (PDA, HP iPAQ 
[Hewlett Packard, Palo Alto, CA, USA]).
Recruitment of participants and data collection
Eligible participants were between 15 and 64  years old, and 
recruitment was conducted over two consecutive days for each 
participant. On day one the questionnaire was administered and 
anthropometric measurements performed, while blood pressure 
measurements and laboratory tests were performed on day two. 
Formal written consent was obtained from each selected 
participant. Participants with abnormal physical or laboratory 
examination as defined below were counselled and referred to 
their nearest health facility for further examination and follow-
up. Physical measurements and laboratory tests were performed 
by nurses and clinical officers who conducted the interviews. A 
total of five survey teams, each with five members, were deployed 
to collect data over a period of 20 days between September and 
December 2009.
Demographic and lifestyle data collection
Demographic and lifestyle data were collected using the WHO 
STEPS questionnaire. The questionnaire was programmed on 
PDA to collect the core (age, sex and education level), expanded 
(rural/urban setting, occupation, average household income) 
and optional (marital status, medical and health history) 
variables.
The medical and health history component included questions 
on medications, existing diabetes mellitus and hypertension. 
The French questionnaire was translated into the main local 
languages (Sussu, Fulani, Maninka and Nguerze) for those 
participants who do not understand French.
Biochemical measurements
On the first day of the survey, participants were asked to observe 
an overnight fast, except water as beverage after supper/dinner 
until the next visit of the survey team in the morning of the 
following day (day 2). Participants were then asked to converge 
at the agreed gathering places in their community where finger-
prick blood samples were taken. Fasting blood glucose and total 
cholesterol were measured using Accutrend® Plus devices 
(Roche, Mannheim, Germany). The machines were calibrated 
every day using the glucose and cholesterol control strips as per 
the manufacturer’s instructions.
Variables, measures and definitions
The socio-demographic variables included were age group, sex, 
and level of education (none, primary/secondary school and 
higher). Locality was classified as Conakry, Urban and Rural areas 
of Lower Guinea. Body mass index (BMI) was calculated as weight 
in kilograms (kg) divided by height in square metres (m²). 
Overweight was defined as BMI 25–29.9  kg/m² and obesity as 
BMI  ≥  30  kg/m². Waist circumference was measured using a 
flexible tape. Hypertension was defined as a systolic (SBP) ≥ 
140 mmHg and/or a diastolic blood pressure (DBP) ≥ 90 mmHg 
or current treatment with antihypertensive agents.15
Pre-diabetes was defined as impaired fasting glucose (IFG) ≥ 
6.1 mmol/L (110 mg/dl) and < 7.0 mmol/L (126 mg/dl). Diabetes 
was defined as fasting capillary blood glucose ≥ 7.0 mmol/L (≥ 
126  mg/dl) or currently on medication for diabetes mellitus 
(documented in the health booklet).16 Participants with diabetes 
were considered to be aware of their status if they answered ‘yes’ 
to the question ‘Have you ever been told by a doctor or health 
professional that you had diabetes?’. As HbA1c was not 
performed in this study, glycaemia was considered controlled if 
fasting capillary glucose ≤ 7.0 mmol/L (126 mg/dl) for participants 
who were aware of their diabetes status. Hypercholesterolemia 
was defined as total cholesterol  ≥  200  mg/L (≥5.2  mmol/L) or 
previous diagnosis and on drug treatment.17
Data management and statistical analysis strategy
Data were collected electronically using PDAs programmed with 
WHO e-STEPS software. Data on the PDAs were downloaded 
onto a computer with WHO NCD STEPS software installed. Data 
were weighted by calculating sample weights for all records 
using the probability of selection at each stage of sampling. 
Thus, for each participant his/her weight was calculated by 
multiplying the probability of the cluster’s selection by the 
probability of household selection, the probability of participant 
selection within the household and age–sex population 
distribution in Guinea. The participant’s weight was equal to the 
inverse of this product. For this paper, participants between the 
ages of 35 years and 64 years were included because of the high 
risk of type 2 diabetes in this age group.6,9 Thus, a total of 1 100 
people out of 2 491 were analysed.
The prevalence of diabetes and pre-diabetes was calculated as 
the total number of people with diabetes or pre-diabetes 
respectively, divided by the total study sample, presented as a 
percentage. Results are summarised as count and percentages 
for categorical variables and mean and standard deviation (SD) 
for quantitative variables, separately for men and women. Age-
sex standardised prevalence was calculated using the latest 
Guinea national population’s age structure in 1996 as the 
standard population, and direct standardisation methods.14 
Ninety-five per cent confidence intervals were calculated for 
prevalence. Comparison of groups was done using chi-square 
tests for categorical variables, and Student’s t-test and analysis of 
variance (ANOVA) for quantitative variables.
Logistic regression analyses with weighted data were used to 
investigate potential determinants of diabetes or undiagnosed 
diabetes. We conducted stratified analysis by sex and all variables 
found to be associated with diabetes (p < 0.10) in bivariate 
analyses were entered into a multivariable logistic regression 
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model. Multivariate logistic regression modelling, using forward 
selection methods, was performed to examine factors associated 
with diabetes, or undiagnosed diabetes independently. 
Candidate predictors were age groups (35–44, 45–54 and 55–
64  years), sex, education (no formal education, primary and 
higher school), setting (urban for localities of Conakry and urban 
Lower Guinea, rural for rural Lower Guinea), BMI (< 25, 25–29.9 
and ≥ 30 kg/m2), waist circumference (< 94 cm (men)/< 80 cm 
(women) and  ≥  94  cm (men)/≥ 80  cm (women), hypertension 
and hypercholesterolemia status. Interaction terms with sex or 
setting were tested and lack of multicollinearity between the 
independent variables of the model was verified. Further, a fully 
adjusted model was established. This model is based on the 
earlier Hosmer–Lemeshow test. A p-value  <  0.05 indicated 
statistically significant results. Data analysis was conducted using 
SAS (version 9.3; SAS Institute, Cary, NC, USA).
Ethics statement
The study was approved by the National Ethical Committee of 
Guinea. Participants detected with disease and abnormal 
findings were referred for treatment to an appropriate health 
facility. Informed consent was obtained from all individuals 
selected for the study. All data were analysed anonymously, 
according to the Declaration of Helsinki.18
Results
The overall profile of the 1 100 participants (512 women; 46.6%) 
included is provided in Table 1. The majority (60.9%) of participants 
were urban dwellers (Conakry and urban Lower Guinea residents). 
The mean age of participants was 47.3 years (SD 8.8), similarly in 
Conakry, rural Lower Guinea and urban Lower Guinea. Participants 
from rural areas in Lower Guinea frequently had no formal educa-
tion and had a lower prevalence of hypercholesterolemia than par-
Table 1: General characteristics of the study population overall and by locality among adults in Guinea
aAge and sex standardised according to the 1996 Guinean national population distribution; SD = standard deviation; BMI = body mass index.
bHypercholesterolemia was missing from 23 subjects.
cBMI was missing from 25 subjects; data are presented as the mean (standard deviation, SD) or number (percentage).




p-value Total age–sex 
standardised (%)a
n 1 100 449 221 430
Sex Female 512 (46.5%) 221(49.2%) 112 (50.7%) 179 (41.6%) 0.03 (52.5%)
Male 588 (53.5%) 228 (50.8%) 109 (49.3%) 251 (58.4%) (47.5%)
Age 35–44 451 (41.0%) 186 (41.4%) 85 (38.5%) 180 (41.9%) 0.88 (47.7%)
45–54 373 (33.9%) 155 (34.5%) 76 (34.4%) 142 (33.0%) (31.8%)
55–64 276 (25.1%) 108 (25.1%) 60 (27.2%) 108 (25.1%) (20.5%)
Mean age, years 
(±SD)
47.3 (±8.8) 47.2 (±8.7) 47.8 (±8.6) 47.0 (±9.1) 0.53 45.9 (±8.6)
Education No formal education 671 (61.0%) 200 (44.5%) 108 (48.9%) 363 (84.4%) < 0.001 (67.5%)
Primary and high 429 (39.0%) 249 (55.5%) 113 (51.1%) 67 (15.6%) (32.5%)
Hypertension Yes 553 (50.3%) 218 (48.6%) 127 (57.5%) 208 (48.4%) 0.04 (50.3%)
No 547 (49.7%) 231 (51.4%) 94 (42.5%) 222 (51.6%) (49.7%)
Mean systolic blood 
pressure(±SD)
142.3 (±26.8) 139.5 (±25.8) 147.3 (±28.7) 142.6 (±26.5) 0.002 142.1 (±26.2)
Mean diastolic blood 
pressure (±SD)
85.2 (±13.9) 85.3 (±14.5) 88.5 (±14.5) 83.3 (±12.7) < 0.001 85.2 (±13.8)
Hypercholester-
olemiab
< 200 mg/L 956 (88.8%) 366 (83.9%) 181 (82.3%) 409 (97.1%) < 0.001 (90.7%)
≥ 200 mg/L 121 (11.2%) 70 (16.1%) 39 (17.7%) 12 (2.9%) (9.3%)
Mean cholesterol, 
mg/L (±SD)
168.8 (±23.5) 174.8 (±26.1) 174.7 (±25.3) 159.7 (±15.3) < 0.001 166.7 (±22.5)
BMI (kg/m2)c <25 732 (68.1%) 269 (61.5%) 118 (53.9%) 345 (82.3%) < 0.001 (69.3%)
25–29.9 221 (20.6%) 93 (21.3%) 66 (30.1%) 62 (14.8%) (21.2%)
≥30 122 (11.3%) 75 (17.2%) 35 (16.0%) 12 (2.9%) (9.5%)
Mean body mass 
index, kg/m2 (±SD)
23.8 (±5.6) 24.9 (±6.4) 25.3 (±5.7) 21.8 (±3.7) < 0.001 23.6 (±5.3)
Waist circumference 
(cm)
≥ 80 (women) or ≥ 
94 (men)
446 (40.5%) 218 (48.6%) 116 (52.5%) 112 (26.0%) < 0.001 (40.7%)
< 80 (women) or < 
94 (men)
654 (59.5%) 231 (51.4%) 105 (47.5%) 318 (74.0%) (59.3%)
Mean waist circum-
ference (±SD)
85.4 (±13.0) 87.8 (±13.7) 88.1 (±15.1) 81.4 (±9.7) < 0.001 84.8 (±12.5)
Mean glycaemia, 
mg/dl (±SD)
79.8 (±30.6) 80.2 (±30.55) 79.5 (±30.2) 79.4 (±30.9) 0.96 77.9 (±28.2)
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Age–sex standardised prevalence of awareness, 
treatment and control of diabetes
Table 2 shows that age–sex standardized prevalence of 
awareness among diabetic participants was significantly higher 
in Conakry (60.4%) and urban Lower Guinea (57.3%) than rural 
Lower Guinea (11.3%), p < 0.0001. Among all participants with 
diabetes, 58.8% (39.7–75.5) were undiagnosed before the survey. 
The prevalence of screen-detected diabetes across other major 
subgroups was 59.2% (men) and 58.4% (women, p = 0.2); 82.6% 
(35–44 years), 65.9% (45–54 years) and 34.7% (54–64 years, p < 
0.0001); 71.3% (no formal education), 32.8% (primary and high 
school, p < 0.0001); 58.2% (non-obese) and 60.4% (obese, p = 
0.001); 70.6% (no hypertension) and 55.7% (hypertension, p < 
0.0001); and 63.7% (no hypercholesterolemia) vs. 39.2% 
(hypercholesterolemia, p < 0.0001).
The age–sex standardised treatment rate for diabetes was 53.6% 
among aware diabetic subjects  (Table 2). Among diabetes 
subjects on treatment, insulin alone (25.2%), oral glucose control 
agents alone (23.5%) and the combination of both (4.9%) were 
the main treatment regimens. Furthermore 27.3% of diabetic 
participants on treatment were also using herbal/traditional 
medicines. Among all of the diabetic subjects, the prevalence of 
current use of herbal/traditional medicines was 28.1%.
Of the diabetic participants receiving treatments, blood sugar 
was at target control levels in 66.3% (Table 2). The age–sex 
standardised prevalence of controlled glycaemia among 
diabetics was 57.5% (insulin alone), 75.4% (oral glucose control 
agents alone) and 61.4% (oral glucose control agents + insulin, p 
< 0.0001).
Table 3 shows the characteristics associated with diabetes in a 
logistic regression. In multivariable models without interaction 
terms, diabetes was significantly associated with male sex (odds 
ratio: 1.40 [95% confidence interval: 1.36–1.44]), urban setting 
(1.30 [1.26–1.34]), age 45–54 (2.00 [1.93–2.06]), age 55–64 (2.37 
[2.29–2.46]), no formal education (1.15 [1.11–1.18]), waist 
ticipants in Conakry and urban Lower Guinea (all p < 0.0001). 
Women were significantly heavier, less educated, and had a higher 
prevalence of hypercholesterolemia than men (p < 0.0001).
The age–sex standardised prevalence of diabetes was 5.7% (95% 
CI 4.0–8.1) overall, 6.4% (4.2–9.7) in women and 4.9% (3.2–7.4) in 
men, p < 0.0001. The standardised prevalence of diabetes 
increased significantly with age in both rural and urban areas, 
p < 0.0001 (Figure 1). Overall, this prevalence was lowest in the 
age group 35–44  years (2.8%: 1.1–6.6) and highest in the 
age group 55–64  years (9.9%: 6.1–15.5). The prevalence of 
diabetes was higher among urban participants (7.4%: 5.3–10.2) 
than rural participants (4.2%: 1.9–9.1), p < 0.0001. The 
prevalence of diabetes across other major subgroups was 
4.7% (non-obese) and 16.1% (obese, p < 0.0001); 2.3% (no 
hypertension) and 9.1% (hypertension, p < 0.0001); and 5.1% 
(no hypercholesterolemia) vs. 12.8% (hypercholesterolemia, 
p < 0.0001).
Figure 1: Prevalence of diabetes in the adult population in Guinea by 
age group (35–44, 45–54, 55–64) and by area (rural and urban). Data 
presented are percentage of patients with diabetes within each group.
Table 2: Prevalence, undiagnosed diabetes status, awareness, treatment and control of diabetes and pre-diabetes by locality
Notes: FBG, fasting blood glucose; CI, confidence interval.
Age and sex standardized according to the 1996 Guinean national population distribution.
All tests were two-sided and a p-value of < 0.05 was considered statistically significant.
aFBG was missing from 1 subject.
Condition Overall n (%) Overall standardized 
% (95% CI)
Standardized % (95% CI) p-value
Conakry  Urban Lower 
Guinea 
 Urban Lower 
Guinea 
n n = 1 100 n = 449 n = 221 n = 430
Pre-diabetes 10 (0.9%) 0.9 (0.4–2.0) 1.3 (0.5–3.4) 0.6 (0.1–4.2) 0.7 (0.2–3.1) < 0.001
Diabetes
FBG > 7.0 mmol/L or 
treatment 
75 (6.8%) 5.7 (4.0–8.1) 7.3 (4.9–10.9) 7.5 (4.4–12.4) 4.2 (2.5–6.9) < 0.001
Screened-detected dia-
betes among diabetics
42 (56.0%) 58.8 (43.8–72.2) 39.6 (22.2–60.1) 42.7 (19.8–69.3) 88.7 (69.2–96.5)
Awareness among 
diabetics 
33 (44.0%) 41.2 (27.8–56.2) 60.4 (39.9–77.8) 57.3 (30.7–80.2) 11.3 (3.5–30.8) < 0.001
Treatment among aware 
diabetics 
21 (63.6%) 53.6 (30.9–74.9) 55.0 (25.9–81.1) 46.8 (16.6–79.5) 58.1 (10.9–94.0) < 0.001
Control among treated 
diabeticsa
9 (45.0%) 66.3 (37.1–86.7) 94.4 (73.4–99.0) 8.1 (0.8–48.7) – < 0.001
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hypercholesterolemia (3.09 [2.95–3.25]) were positively 
associated with diabetes among males.
In the urban setting, diabetes was positively associated with 
male sex (1.64 [1.57–1.71]), age 45–54 (3.25 [3.09–3.41]), age 
55–64 (4.66 [4.42–4.91]), waist circumference (2.44 [2.34–2.55]), 
hypertension (3.69 [3.53–3.85]) and hypercholesterolemia (1.42 
[1.37–1.48]) (Table 4); while no formal education (0.96 [0.93–
0.99]), was inversely associated with diabetes risk. In the rural 
population, diabetes was positively associated with male sex 
(1.32 [1.26–1.39]), age 45–54 (1.51 [1.43–1.58]), age 55–64 (1.16 
[1.11–1.23]), no formal education (1.83 [1.71–1.96]), waist 
circumference (3.92 [3.74–4.12]), hypertension (2.15 [2.06–2.25]) 
and hypercholesterolemia (1.57 [1.42–1.74]).
In the subsample short of participants without diabetes known be-
fore study, male sex (odds ratio 2.03 [95% CI 1.95–2.11]), rural resi-
circumference (2.78 [2.70–2.88]), hypertension (2.94 [2.85–3.03]) 
and hypercholesterolemia (1.48 [1.43–1.54]). The interactions 
between sex and setting, age, education level, waist 
circumference, hypertension and hypercholesterolemia were 
significant (all p < 0.0001). The interactions between setting and 
age, education level, waist circumference, hypertension and 
hypercholesterolemia were significant (all p  ≤  0.01). After 
stratifying the data by sex, age 45–54 (1.48 [1.42–1.54]), age 55–
64 (1.54 [1.47–1.61]), waist circumference (4.69 [4.43–4.97]), and 
hypertension (5.46 [5.21–5.73]) were significantly and positively 
associated with diabetes among females (Table 4); while urban 
setting (0.90 [0.86–0.94]), hypercholesterolemia (0.85 [0.81–
0.90]) and no formal education (0.74 [0.71–0.77]) were inversely 
associated with diabetes risk. Urban setting (1.96 [1.87–2.05]), 
age 45–54 (4.36 [4.08–4.66]), age 55–64 (6.16 [5.76–6.58]), no 
formal education (1.89 [1.81–1.97]), waist circumference (1.90 
[1.81–1.99]), hypertension (1.49 [1.43–1.56]) and 
Table 3: Crude and adjusted odds ratios for associated risk factors of 
diabetes among adults in Guinea
Notes: BMI = body mass index; CI, = confidence interval.
Associations were studied using stepwise logistic regression and expressed 
as odds ratios (ORs) with 95% confidence intervals (CIs).
Variable Crude OR 
(95% CI)
p-value Adjusted OR 
(95% CI)
p-value
Sex < 0.0001 < 0.0001
 Female 1.00 (reference) 1.00 (reference)
 Male 0.75 (0.73–0.77) 1.40 (1.36–1.44)
Setting < 0.0001 < 0.0001
 Rural 1.00 (reference) 1.00 (reference)
 Urban 1.82 (1.77–1.87) 1.30 (1.26–1.34)
Age groups < 0.0001 < 0.0001
 35–44 1.00 (reference) 1.00 (reference)
 45–54 2.83 (2.74–2.92) 2.00 (1.93–2.06)
 55–64 3.84 (3.72–3.97) 2.37 (2.29–2.46)
Education level 0.45 < 0.0001
 Primary and 
high school
1.00 (reference) 1.00 (reference)
 No formal 
education
0.99 (0.96–1.02) 1.15 (1.11–1.18)
BMI (kg/m2) < 0.0001
 < 25 1.00 (reference)
 25–29.99 1.83 (1.78–1.89)
 ≥ 30 4.63 (4.49–4.77)
Waist circum-
ference
< 0.0001 < 0.0001
 < 80 cm 
(women) or < 
94 cm(men)
1.00 (reference) 1.00 (reference)
 ≥ 80 cm 
(women) or ≥ 
94 cm (men)
3.25 (3.17–3.33) 2.78 (2.70–2.88)
Hypertensive <0.0001 <0.0001
 No 1.00 (reference) 1.00 (reference)




 < 200 mg/L 1.00 (reference) 1.00 (reference)
 ≥ 200 mg/L 2.72 (2.63–3.80) 1.48 (1.43–1.54)
Table 4: Adjusted odds ratios for associated risk factors of diabetes by 
sex and setting in Guinea















45–54 1.48 (1.42–1.54) < 0.0001 4.36 
(4.08–4.66)
< 0.0001




0.74 (0.71–0.77) < 0.0001 1.89 
(1.81–1.97)
< 0.0001
Waist ≥ 80 
(women) 
or ≥ 94 
(men)


























45–54 3.25 (3.09–3.41) < 0.0001 1.51 
(1.43–1.58)
< 0.0001




0.96 (0.93–0.99) 0.02 1.83 
(1.71–1.96)
< 0.0001
Waist ≥ 80 
(women) 
or ≥ 94 
(men)











Yes 1.42 (1.37–1.48) < 0.0001 1.57 
(1.42–1.74)
< 0.0001
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hypercholesterolemia (3.09 [2.95–3.25]) were positively 
associated with diabetes among males.
In the urban setting, diabetes was positively associated with 
male sex (1.64 [1.57–1.71]), age 45–54 (3.25 [3.09–3.41]), age 
55–64 (4.66 [4.42–4.91]), waist circumference (2.44 [2.34–2.55]), 
hypertension (3.69 [3.53–3.85]) and hypercholesterolemia (1.42 
[1.37–1.48]) (Table 4); while no formal education (0.96 [0.93–
0.99]), was inversely associated with diabetes risk. In the rural 
population, diabetes was positively associated with male sex 
(1.32 [1.26–1.39]), age 45–54 (1.51 [1.43–1.58]), age 55–64 (1.16 
[1.11–1.23]), no formal education (1.83 [1.71–1.96]), waist 
circumference (3.92 [3.74–4.12]), hypertension (2.15 [2.06–2.25]) 
and hypercholesterolemia (1.57 [1.42–1.74]).
In the subsample short of participants without diabetes known be-
fore study, male sex (odds ratio 2.03 [95% CI 1.95–2.11]), rural resi-
circumference (2.78 [2.70–2.88]), hypertension (2.94 [2.85–3.03]) 
and hypercholesterolemia (1.48 [1.43–1.54]). The interactions 
between sex and setting, age, education level, waist 
circumference, hypertension and hypercholesterolemia were 
significant (all p < 0.0001). The interactions between setting and 
age, education level, waist circumference, hypertension and 
hypercholesterolemia were significant (all p  ≤  0.01). After 
stratifying the data by sex, age 45–54 (1.48 [1.42–1.54]), age 55–
64 (1.54 [1.47–1.61]), waist circumference (4.69 [4.43–4.97]), and 
hypertension (5.46 [5.21–5.73]) were significantly and positively 
associated with diabetes among females (Table 4); while urban 
setting (0.90 [0.86–0.94]), hypercholesterolemia (0.85 [0.81–
0.90]) and no formal education (0.74 [0.71–0.77]) were inversely 
associated with diabetes risk. Urban setting (1.96 [1.87–2.05]), 
age 45–54 (4.36 [4.08–4.66]), age 55–64 (6.16 [5.76–6.58]), no 
formal education (1.89 [1.81–1.97]), waist circumference (1.90 
[1.81–1.99]), hypertension (1.49 [1.43–1.56]) and 
Table 3: Crude and adjusted odds ratios for associated risk factors of 
diabetes among adults in Guinea
Notes: BMI = body mass index; CI, = confidence interval.
Associations were studied using stepwise logistic regression and expressed 
as odds ratios (ORs) with 95% confidence intervals (CIs).
Variable Crude OR 
(95% CI)
p-value Adjusted OR 
(95% CI)
p-value
Sex < 0.0001 < 0.0001
 Female 1.00 (reference) 1.00 (reference)
 Male 0.75 (0.73–0.77) 1.40 (1.36–1.44)
Setting < 0.0001 < 0.0001
 Rural 1.00 (reference) 1.00 (reference)
 Urban 1.82 (1.77–1.87) 1.30 (1.26–1.34)
Age groups < 0.0001 < 0.0001
 35–44 1.00 (reference) 1.00 (reference)
 45–54 2.83 (2.74–2.92) 2.00 (1.93–2.06)
 55–64 3.84 (3.72–3.97) 2.37 (2.29–2.46)
Education level 0.45 < 0.0001
 Primary and 
high school
1.00 (reference) 1.00 (reference)
 No formal 
education
0.99 (0.96–1.02) 1.15 (1.11–1.18)
BMI (kg/m2) < 0.0001
 < 25 1.00 (reference)
 25–29.99 1.83 (1.78–1.89)
 ≥ 30 4.63 (4.49–4.77)
Waist circum-
ference
< 0.0001 < 0.0001
 < 80 cm 
(women) or < 
94 cm(men)
1.00 (reference) 1.00 (reference)
 ≥ 80 cm 
(women) or ≥ 
94 cm (men)
3.25 (3.17–3.33) 2.78 (2.70–2.88)
Hypertensive <0.0001 <0.0001
 No 1.00 (reference) 1.00 (reference)




 < 200 mg/L 1.00 (reference) 1.00 (reference)
 ≥ 200 mg/L 2.72 (2.63–3.80) 1.48 (1.43–1.54)
Table 4: Adjusted odds ratios for associated risk factors of diabetes by 
sex and setting in Guinea















45–54 1.48 (1.42–1.54) < 0.0001 4.36 
(4.08–4.66)
< 0.0001




0.74 (0.71–0.77) < 0.0001 1.89 
(1.81–1.97)
< 0.0001
Waist ≥ 80 
(women) 
or ≥ 94 
(men)


























45–54 3.25 (3.09–3.41) < 0.0001 1.51 
(1.43–1.58)
< 0.0001




0.96 (0.93–0.99) 0.02 1.83 
(1.71–1.96)
< 0.0001
Waist ≥ 80 
(women) 
or ≥ 94 
(men)











Yes 1.42 (1.37–1.48) < 0.0001 1.57 
(1.42–1.74)
< 0.0001
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health literacy among people with limited formal education, but 
also possibly the effects of low socio-economic status, considering 
that low education is a good surrogate of low socio-economic 
position, a major determinant of the access to health care.24
In the current study, male, urban setting, increasing age, waist 
circumference, hypertension and hypercholesterolemia were 
the major variables steady associated with diabetes, which is 
consistent with other reports.12,25–27 Other findings from this 
study show that diabetes is associated with major modifiable 
cardiovascular risk factors including hypertension, waist 
circumference and hypercholesterolemia, reflecting the 
constellation of cardiometabolic risk factors. Indeed, metabolic 
syndrome has been reported at a high frequency among 
Guinean people with type 2 diabetes, of which hypertension and 
obesity were principal components.28 This constellation of risk 
factors likely indicates the importance of an absolute risk 
approach to cardiometabolic risk reduction in this population, as 
opposed to strategies based on single risk factors.
Among the limitations of the present study is its cross-sectional 
design. We cannot therefore demonstrate causality of the association 
with the factors evident in the present study. Also, we did not analyse 
the nutritional status or physical activity in this study, which are well-
known risk factors for diabetes and dysglycaemia. The second 
limitation is related to the fact that diagnosis of diabetes was based 
on a fasting glucose test only. Without oral glucose tolerance test 
results, the estimated prevalence of 6.6% could be lower than the 
real prevalence, considering that early-stage diabetes among 
Africans tends to be reflected more on post-load and not fasting 
glucose. Indeed, in a report from South Africa, the prevalence of 
diabetes was 36% lower (2.5% vs. 3.9%) when only fasting plasma 
glucose results were used than when an oral glucose tolerance test 
was used.25 Glycated haemoglobin (HbAlc) is the gold-standard 
marker to assess the control of diabetes. The FBG used in this study is 
a limitation in this respect and was only intended to show a general 
trend. We did not include individuals older than 64  years, an age 
group in which the prevalence of diabetes is likely to be particularly 
high.29 Despite these limitations, this study provides important data 
regarding the prevalence and the factors associated with diabetes, 
and information on diabetes care in Guinea.
Conclusion
This study has confirmed the high prevalence of diabetes and 
assessed the related risk factors in the region of Lower Guinea 
including Conakry. Because of this high prevalence, which mostly 
comprised prevalent undiagnosed diabetes that tends to be more 
predominant in some segments of the population, there is a 
substantial margin to consider targeted screening a strategy to 
improve diabetes detection in this population. Such strategies 
should ultimately include actions to prevent the development of 
the disease among those with identified risk factors of diabetes.
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dency (1.57 [1.52–1.63]), age group 45–54 years (1.82 [1.75–1.89]), 
no formal education (2.29 [2.19–2.39]), waist circumference (4.81 
[4.61–5.02]), hypertension (2.55 [2.45–2.64]) and hypercholester-
olemia (1.39 [1.32–1.47]) were significant predictors of screen-de-
tected diabetes; while age group 55–64 years (0.93 [0.89–0.98]) was 
inversely associated with screen-detected diabetes risk.
Discussion
This study, the largest and the most representative in the country 
since the Futa Jallon study, has confirmed the high prevalence of 
diabetes among Guinean populations, and highlighted the 
critical need for action in prevention and early detection of the 
disease.12 Indeed, while almost 7 in 100 adults in the study had 
prevalent diabetes, over half of those with the disease were 
discovered only during the survey. There was further evidence 
that the drivers of diabetes in this population were largely those 
already reported in other African populations and in particular 
advanced age, waist circumference and adiposity, while low 
education and rural residency emerged as drivers of low 
awareness of existing diabetes. The age–sex standardised 
prevalence of diabetes was high in this Guinean study, particularly 
among urban dwellers and the age group 55–64  years. Our 
overall prevalence is consistent with findings from the Futa Jallon 
study in Guinea.12 Our findings are, however, likely more 
representative of the Guinean population, considering that the 
study was also conducted in Conakry where all major ethnic 
groups of the country are represented. Data available from STEPS 
surveys conducted in other Western African countries have 
revealed various prevalences of diabetes mellitus: Togo 2.6%; 
Benin 3.0%; Ghana 4.5%; Mauritania 6.2%; Liberia 19.2%; and 
Niger 22.5%.19 The results of some studies reveal considerable 
between-country variation in the prevalence of diabetes mellitus 
among adults.6,20 As expected, our data reported that urban 
settings have a higher prevalence of diabetes than rural. Finding 
from various studies have shown a positive rural–urban gradient 
in prevalence of diabetes.6,11 Some studies showed that 
urbanisation and economic development are increasing the 
prevalence of diabetes by about 40%.6,21 Among participants 
identified as having diabetes, the prevalence of screen-detected 
cases of diabetes was 58.8%, and particularly high in rural areas. A 
similar finding was reported in previous studies in Guinea and 
North West Ethiopia.12,22 All of the prevalence surveys in Africa 
that recorded proportions of previously undiagnosed diabetes 
among participants who attended screening programmes found 
very high levels (≥ 40%).9 The high rates of screen-detected 
diabetes suggest that existing screening practices in the region 
are not effective.9 A systematic search for diabetes in the follow-
up reports of hypertensive subjects could explain why these 
subjects with hypertension were more aware of their diabetes. 
The low treatment and control rates in our study reflect the 
interplay between many individual/household and health-
system level factors, many of which were not directly captured in 
the current study. These include among others poor access to 
health facilities, availability and affordability of drugs, poor 
dietary habits and poverty.6,8,9,11 In this study, 57.5% taking insulin 
had controlled glycaemia. This observation most likely reflects 
the phenomenon of reverse causality, i.e. more intensive 
treatment being required with the presence of elevated 
glycaemia. Some other studies have reported the same.8,23 
However, this result should be considered with caution as we 
used only a punctual fasting blood glucose less than 126 mg/dl as 
glycaemia control criterion. Indeed, diabetes control should be 
assessed by glycated haemoglobin, which was not available in 
the conditions of the study. The associations of screened detected 
diabetes with low education in our sample likely reflect the low 
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